Alzheimer’s disease (Early onset), excluding more controls

AD_EO_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.0, F00.00, F00.00G30.0, G30.0, G30.0+F00.00 Cause of death:* ICD-10 — F00.0, F00.00, F00.00*G30.0, G30.0, G30.0+F00.00 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: G6_AD_STRICT, F5_DEMENTIA, F5_DEMENTIA_U, F5_PSYCH, NEURODIS, MEMLOSS, TRAUMBRAIN_NONCONCUS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	AD_EO_EXMORE
CONTROL_EXCLUDE	G6_AD_STRICT\|F5_DEMENTIA\|F5_DEMENTIA_U\|F5_PSYCH\|NEURODIS\|MEMLOSS\|TRAUMBRAIN_NONCONCUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F000\|G300
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F000\|G300
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease (Early onset), excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alzheimer’s disease (Early onset)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1965	967	998
Unadjusted period prevalence (%)	0.40	0.34	0.46
Median age at first event (years)	75.62	73.65	77.54

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2006: Matched controls
18893

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TAB00

NOMESCO Finland

Lumbar puncture

54.4

307.7

253

F03

ICD-10 Finland

Unspecified dementia

112.5

307.7

454

N03AG01

ATC

valproic acid; systemic, rectal

154.3

307.7

206

N06DA02

ATC

donepezil; oral

1004.4

307.7

1082

P20

ICPC

Memory disturbance

13.2

307.7

739

800

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

1109

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

248.2

307.7

233

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

560.6

307.7

527

P70

ICPC

Dementia

77.8

307.7

272

XA800

NOMESCO Finland

Neuropsychological investigation

79.9

307.7

199

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

5878.0

307.7

801

G30.0

ICD-10 Finland

Alzheimer disease with early onset

16384.0

307.7

1145

N06DX01

ATC

memantine; oral

1065.7

307.7

1229

N05AX08

ATC

risperidone; systemic

80.6

307.7

682

120

G30.1

ICD-10 Finland

Alzheimer disease with late onset

660.2

307.7

936

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

25.6

307.7

624

328

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

307.7

713

N05AH04

ATC

quetiapine; oral

27.9

307.7

583

273

N06DA03

ATC

rivastigmine; oral, transdermal

1064.7

307.7

678

N06DA04

ATC

galantamine; oral

1092.0

304.9

297

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

98.2

297.4

163

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

97.5

295.4

162

F06.7

ICD-10 Finland

Mild cognitive disorder

34.2

284.0

191

F0009, G300,

ICD-10 Finland

+∞

282.3

270

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

58.0

268.4

159

S06.0

ICD-10 Finland

Concussion

25.3

247.8

184

F32.9

ICD-10 Finland

Depressive episode, unspecified

26.3

244.7

179

G30

ICD-10 Finland

Alzheimer disease

829.2

237.5

234

N05AH03

ATC

olanzapine; systemic

50.9

232.2

141

G30.8

ICD-10 Finland

Other Alzheimer disease

316.2

231.7

236

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

1173.5

226.6

222

SPAT1053

SPAT

Memory test

5.4

221.6

547

1219

N05BA04

ATC

oxazepam; oral

4.8

218.5

665

1764

N06AX11

ATC

mirtazapine; oral

4.6

208.7

683

1910

R41.3

ICD-10 Finland

Other amnesia

30.4

207.4

144

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

205.5

198

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

12.3

199.1

213

181

N06AB04

ATC

citalopram; systemic

5.2

194.3

485

1082

N06AB10

ATC

escitalopram; oral

6.6

191.7

351

585

F0019, G301,

ICD-10 Finland

+∞

187.5

181

AA1AD

NOMESCO Finland

CT of head and brain

4.8

186.2

533

1329

SPAT1245

SPAT

Provision of support and information to patient’s family members

8.8

171.2

235

282

R53

ICD-10 Finland

Malaise and fatigue

4.1

161.6

589

1747

Z75.5

ICD-10 Finland

Holiday relief care

28.3

156.7

111

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

12.5

149.2

156

127

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

11.3

144.2

161

145

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

142.4

138

Z2445

NOMESCO Finland

Psychologist

66.2

140.0

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

7.1

136.1

223

327

R56.8

ICD-10 Finland

Other and unspecified convulsions

15.2

136.0

126

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

24.4

135.4

101

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

135.0

131

F009, G309,

ICD-10 Finland

+∞

130.9

127

WYA20

NOMESCO Finland

Home visit

22.0

126.3

R41.0

ICD-10 Finland

Disorientation, unspecified

12.2

123.2

130

107

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.1

122.1

756

3071

A28

ICPC

Limited function/disability NOS

3.5

119.3

543

1830

SPAT1234

SPAT

Support of social functional capacity

6.5

119.1

211

335

N05AD01

ATC

haloperidol; systemic

8.5

117.9

162

193

G47.3

ICD-10 Finland

Sleep apnoea

9.6

112.8

140

146

SPAT1216

SPAT

Assessment of functional ability

3.7

112.8

439

1332

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

7.4

112.6

175

241

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

5.0

110.3

267

566

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

+∞

102.8

100

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.3

102.5

487

1670

N05BA06

ATC

lorazepam; systemic, sublingual

6.3

101.4

183

295

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

97.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.4

96.1

416

1342

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.2

95.3

286

717

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

94.6

785

3635

N05AD03

ATC

melperone; systemic

20.3

93.8

N06AX26

ATC

vortioxetine; oral

12.1

92.3

G40.9

ICD-10 Finland

Epilepsy, unspecified

456.8

91.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

31.2

89.0

G56.0

ICD-10 Finland

Carpal tunnel syndrome

9.2

88.5

113

122

A06AD11

ATC

lactulose; oral

3.0

88.2

493

1843

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

40.9

86.4

N06AB06

ATC

sertraline; oral

6.3

85.1

152

242

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

21.4

84.4

SPAT1254

SPAT

Administration of medicine

3.3

83.6

386

1287

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

+∞

79.0

F05.1

ICD-10 Finland

Delirium superimposed on dementia

+∞

74.8

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

74.3

380

1339

F01.9

ICD-10 Finland

Vascular dementia, unspecified

35.6

72.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

72.7

381

1361

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

9.8

69.5

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.9

66.7

386

1451

N06AX16

ATC

venlafaxine; oral

5.2

65.9

143

273

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

65.5

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

630.8

64.8

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

64.5

F05.9

ICD-10 Finland

Delirium, unspecified

99.0

63.6

N03AX14

ATC

levetiracetam; systemic

24.6

62.1

L28

ICPC

Limited function/disability (L)

2.7

61.2

402

1608

G20

ICD-10 Finland

Parkinson disease

107.1

59.7

SPAT1229

SPAT

Assessment of need for aid

3.8

57.9

191

507

T36

ICD-10 Finland

Poisoning by systemic antibiotics

15.2

56.8

R55

ICD-10 Finland

Syncope and collapse

3.0

54.5

271

931

N03AF02

ATC

oxcarbazepine; oral

21.2

53.6

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

267.3

53.2

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

52.2

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

52.2

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.8

50.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

170.8

49.9

R42

ICD-10 Finland

Dizziness and giddiness

2.4

49.4

424

1908

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

47.0

N05AB03

ATC

perphenazine; systemic, rectal

14.8

46.3

W19

ICD-10 Finland

Unspecified fall

3.3

46.1

192

592

S72.0

ICD-10 Finland

Fracture of neck of femur

3.5

44.6

163

462

N05CD07

ATC

temazepam; oral

2.5

43.5

324

1361

N03AE01

ATC

clonazepam; systemic

6.1

43.1

125

N02AA05

ATC

oxycodone; systemic

2.2

42.5

433

2083

SPAT1251

SPAT

Organisation of medication

4.2

42.3

118

276

K90

ICPC

Stroke/cerebrovascular accident

17.6

41.2

E86

ICD-10 Finland

Volume depletion

5.3

40.9

159

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

391.8

40.3

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

3.6

40.0

141

390

N06AX21

ATC

duloxetine; oral

3.9

39.4

121

304

N03AF01

ATC

carbamazepine; oral, rectal

5.0

39.1

173

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

+∞

38.8

J01CA08

ATC

pivmecillinam; oral

1.9

38.8

719

4278

A10AB05

ATC

insulin aspart; parenteral

3.3

38.8

154

460

N05CF01

ATC

zopiclone; oral

2.0

38.7

632

3604

ACC51

NOMESCO Finland

Release of median nerve

61.8

38.2

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

13.0

38.2

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

131.3

37.9

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

+∞

36.8

A04

ICPC

Weakness/tiredness general

2.5

36.4

259

1061

N02BE01

ATC

paracetamol; systemic, rectal

2.0

36.0

1538

11780

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

35.7

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

+∞

35.7

F00

ICD-10 Finland

Dementia in Alzheimer disease

342.7

35.2

SPAT1246

SPAT

Screening of depression or other psychiatric problem

9.8

35.2

S70.0

ICD-10 Finland

Contusion of hip

4.0

35.1

103

250

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

+∞

34.7

R1250

NOMESCO Finland

Evaluation of functional capability

8.5

34.6

N28

ICPC

Limited function/disability (N)

14.6

34.2

N06AB03

ATC

fluoxetine; oral

3.2

34.1

147

461

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.5

34.0

236

954

F22.0

ICD-10 Finland

Delusional disorder

118.3

33.9

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

33.7

287

1271

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.2

33.4

209

F29

ICD-10 Finland

Unspecified nonorganic psychosis

88.8

33.0

SPAT1301

SPAT

No procedures

1.9

32.8

537

3037

F0029, G308,

ICD-10 Finland

+∞

32.7

N30.0

ICD-10 Finland

Acute cystitis

2.3

32.6

287

1288

N05BA01

ATC

diazepam; systemic, rectal

2.5

32.4

228

927

N30.9

ICD-10 Finland

Cystitis, unspecified

3.2

32.4

139

435

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

32.3

303

1396

G72.8

ICD-10 Finland

Other specified myopathies

313.2

32.2

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.8

32.0

102

263

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

32.0

260

1128

N05AA02

ATC

levomepromazine; systemic

5.6

31.8

107

SPAT1252

SPAT

Overall medication plan or its review

2.9

31.1

155

528

P29

ICPC

Psychological sympt/compl other

7.0

30.7

J01EA01

ATC

trimethoprim; systemic

1.9

30.4

537

3100

G31.0

ICD-10 Finland

Circumscribed brain atrophy

299.0

30.2

N07AA05, ,

ATC

+∞

29.6

F0014, G301,

ICD-10 Finland

+∞

29.6

Z29

ICPC

Social problem NOS

6.8

29.5

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

28.6

Z02.4

ICD-10 Finland

Examination for driving licence

0.4

28.4

145

3191

F32.1

ICD-10 Finland

Moderate depressive episode

11.0

28.0

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

27.5

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

+∞

27.5

N03AX09

ATC

lamotrigine; oral

29.6

27.3

S01.0

ICD-10 Finland

Open wound of scalp

2.9

27.3

136

463

I95.1

ICD-10 Finland

Orthostatic hypotension

3.7

26.9

231

G44.2

ICD-10 Finland

Tension-type headache

3.3

26.6

106

317

N29

ICPC

Neurological sympt/complt other

10.6

26.6

A10AE04

ATC

insulin glargine; parenteral

2.5

26.0

172

677

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.3

26.0

130

Kela drug reimbursment

Malignant tumour

0.2

25.9

1521

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

25.5

116

375

F0004, G300,

ICD-10 Finland

+∞

25.5

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

+∞

25.5

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

+∞

25.5

SPAT1172

SPAT

Guidance concerning hydration

3.8

25.4

200

N05AN01

ATC

lithium; oral

69.4

25.2

SPAT1101

SPAT

Orthostatic test

3.1

24.9

109

345

J01DB01

ATC

cefalexin; oral

1.7

24.9

1297

9897

H04AA01

ATC

glucagon; nasal, parenteral

8.1

24.8

U04

ICPC

Incontinence urine

3.0

24.5

110

353

R51.80

ICD-10 Finland

Headache

2.7

24.5

137

496

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

+∞

24.5

F001, G301,

ICD-10 Finland

+∞

24.5

-, ,

ICD-10 Finland

4.2

24.2

148

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

124.0

24.0

E000001, ,

ATC

1.9

23.8

325

1710

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.4

23.5

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

23.5

303

1564

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

23.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

53.4

23.4

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

228.7

23.1

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

228.7

23.1

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

228.7

23.1

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

119.2

23.0

SPAT1360

SPAT

Extensive global examination

2.7

22.6

130

477

N06AX12

ATC

bupropion; oral

6.8

22.4

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.3

22.1

258

LAITO, ,

NOMESCO Finland

114.3

22.1

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

5.1

21.7

SPAT1304

SPAT

Counselling and guidance related to ageing

2.3

21.6

182

798

S06.2

ICD-10 Finland

Diffuse brain injury

+∞

21.4

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

21.4

N05AH02

ATC

clozapine; systemic

+∞

21.4

SPAT1139

SPAT

Nutrition survey

3.8

21.4

171

R11

ICD-10 Finland

Nausea and vomiting

2.4

21.3

152

620

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

21.2

463

2805

S06.3

ICD-10 Finland

Focal brain injury

209.4

21.1

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

209.4

21.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

20.7

131

504

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

+∞

20.4

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

20.4

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

+∞

20.4

SPAT1050

SPAT

Extensive neurological examination

5.8

20.3

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

199.8

20.1

N05AX12

ATC

aripiprazole; systemic

199.8

20.1

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

199.8

20.1

N87

ICPC

Parkinsonism

104.7

20.1

F34.1

ICD-10 Finland

Dysthymia

31.0

19.6

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.4

19.6

200

N05BE01

ATC

buspirone; oral

8.0

19.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

19.3

248

1273

N04AA02

ATC

biperiden; systemic

34.0

19.3

N06AX03

ATC

mianserin; oral

3.8

18.9

150

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

18.9

632

4247

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.6

18.8

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

18.8

150

642

N06AA09

ATC

amitriptyline; systemic

2.5

18.7

123

482

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

18.7

168

755

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

43.8

18.7

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.6

18.7

SPAT1240

SPAT

Therapeutic discussion

3.5

18.6

174

N06AG02

ATC

moclobemide; oral

4.2

18.6

114

P76

ICPC

Depressive disorder

5.7

18.4

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

+∞

18.4

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

+∞

18.4

F000, G300,

ICD-10 Finland

+∞

18.4

SPAT1307

SPAT

Psychosocial counselling and guidance

5.4

18.3

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.6

18.1

159

G45.3

ICD-10 Finland

Amaurosis fugax

180.6

18.1

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.7

18.1

A29

ICPC

General symptom/complaint other

2.0

17.9

207

1024

B01AC07

ATC

dipyridamole; systemic

2.4

17.8

123

494

J01MA02

ATC

ciprofloxacin; systemic

1.5

17.7

686

4752

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

5.9

17.5

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

5.2

17.3

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

+∞

17.3

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

17.3

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

17.3

35399

ICD-8 Finland

Sciatica

+∞

17.3

N04BD01

ATC

selegiline; oral

63.3

17.3

F32

ICD-10 Finland

Depressive episode

5.6

17.2

C04AE01

ATC

ergoloid mesylates; systemic

5.5

16.9

P01

ICPC

Feeling anxious/nervous/tense

3.7

16.9

140

N03AB02

ATC

phenytoin; systemic

14.8

16.9

F05.8

ICD-10 Finland

Other delirium

47.5

16.5

SPAT1263

SPAT

Sampling

1.6

16.5

591

4010

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

16.4

350

C10AA01

ATC

simvastatin; oral

1.5

16.3

825

6017

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.8

16.3

130

G41.9

ICD-10 Finland

Status epilepticus, unspecified

+∞

16.3

SPAT1104

SPAT

Monitoring of emergency patient

2.5

16.2

108

427

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

16.1

143

640

H02AB02

ATC

dexamethasone; systemic

0.3

15.8

1338

SPAT1167

SPAT

Insertion of urinary catheter

2.9

15.7

250

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

28.5

15.6

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

2.1

15.6

159

750

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.5

15.6

N05AF03

ATC

chlorprothixene; systemic

19.9

15.5

N06AB05

ATC

paroxetine; oral

3.5

15.4

149

G04BD07

ATC

tolterodine; oral

2.4

15.4

107

431

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

+∞

15.3

G81.9

ICD-10 Finland

Hemiplegia, unspecified

+∞

15.3

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

+∞

15.3

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

15.3

F0001, G300,

ICD-10 Finland

+∞

15.3

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

+∞

15.3

F0009, G309,

ICD-10 Finland

+∞

15.3

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

+∞

15.3

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

15.3

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

80.8

15.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

15.1

233

1268

N05BA12

ATC

alprazolam; oral

2.2

14.9

124

540

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

14.8

301

N06AA12

ATC

doxepin; systemic

2.8

14.6

260

P03

ICPC

Feeling depressed

3.7

14.5

119

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

53.8

14.4

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

+∞

14.3

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

14.3

F20.9

ICD-10 Finland

Schizophrenia, unspecified

+∞

14.3

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

+∞

14.3

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

76.0

14.2

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

17.4

14.2

IGY02

NOMESCO Finland

Psychiatric monitoring contact

142.3

14.1

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

142.3

14.1

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

34.2

14.0

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

14.0

225

1238

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.8

14.0

A69

ICPC

General and Unspecified, Other reason for encounter NEC

3.1

13.5

177

P28

ICPC

Limited function/disability (P)

28.5

13.5

P72

ICPC

Schizophrenia

50.6

13.4

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

14.9

13.4

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.9

13.4

219

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

16.6

13.4

AXX01, ,

SPAT

3.5

13.3

126

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

13.3

379

2426

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

+∞

13.2

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

13.2

G40.10

ICD-10 Finland

Simple partial seizures

+∞

13.2

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

+∞

13.2

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

+∞

13.2

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

13.2

N05AF05

ATC

zuclopenthixol; systemic

+∞

13.2

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

+∞

13.2

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

+∞

13.2

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

13.2

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

13.2

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

71.2

13.2

A10AE05

ATC

insulin detemir; parenteral

2.5

13.2

314

F10.09

ICD-10 Finland

Alcohol intoxication UNS

132.7

13.1

SPAT1262

SPAT

Handing over of treatment supplies

1.7

13.1

258

1505

N18

ICPC

Paralysis/weakness

12.2

12.9

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

12.8

128

600

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

37.9

12.8

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

12.8

137

659

SPAT1276

SPAT

Outlining of treatment with patient or their family members

3.4

12.8

125

G56.2

ICD-10 Finland

Lesion of ulnar nerve

11.5

12.6

R32

ICD-10 Finland

Unspecified urinary incontinence

3.3

12.5

141

F21, ,

ICPC

5.6

12.5

N03AX16

ATC

[U] pregabalin

1.7

12.4

258

1526

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

12.2

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

+∞

12.2

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

12.2

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

12.2

J01DA01

ATC

[U] cefalexin

1.4

12.0

1022

8051

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

8.8

11.9

E0000UV, ,

ATC

1.5

11.9

574

4091

H02AA02

ATC

fludrocortisone; oral

6.0

11.9

N05AC02

ATC

thioridazine; oral

11.0

11.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

11.8

270

1635

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

11.7

441

2993

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

11.7

432

2920

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

11.6

388

2567

A01

ICPC

Pain general/multiple sites

2.1

11.6

113

525

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

3.6

11.5

101

Z28

ICPC

Limited function/disability (Z)

11.1

11.4

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

5.5

11.3

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

61.5

11.3

S01.9

ICD-10 Finland

Open wound of head, part unspecified

4.3

11.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

28.4

11.3

F10.20

ICD-10 Finland

Alcohol dependence currently independent

28.4

11.3

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

28.4

11.3

G40

ICD-10 Finland

Epilepsy

+∞

11.2

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

11.2

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

+∞

11.2

N07AA06, ,

ATC

+∞

11.2

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

+∞

11.2

N19

ICPC

Speech disorder

21.7

11.2

G04CA02

ATC

tamsulosin; oral

1.5

11.2

465

3213

D07AA02

ATC

hydrocortisone; topical

1.8

11.2

185

1025

AAF00

NOMESCO Finland

Ventriculostomy

113.7

11.2

A10AB04

ATC

insulin lispro; parenteral

3.4

11.1

108

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

11.1

322

S22.3

ICD-10 Finland

Fracture of rib

2.1

11.0

446

G03CA04

ATC

estriol; systemic, vaginal

1.8

11.0

164

882

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

11.0

449

3093

R50.9

ICD-10 Finland

Fever, unspecified

1.7

10.8

214

1247

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.5

10.7

1780

T90.5

ICD-10 Finland

Sequelae of intracranial injury

41.0

10.6

WX402

NOMESCO Finland

General anaesthesia

0.5

10.6

1553

A10AC01

ATC

insulin (human); parenteral

1.8

10.5

149

788

W06

ICD-10 Finland

Fall involving bed

5.6

10.5

N06AX05

ATC

trazodone; oral

5.6

10.5

S00.0

ICD-10 Finland

Superficial injury of scalp

3.4

10.4

104

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

20.3

10.3

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

10.3

138

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

10.2

WX780

NOMESCO Finland

Remote monitoring CPAP

+∞

10.2

F009, F03,

ICD-10 Finland

+∞

10.2

F0001, G301,

ICD-10 Finland

+∞

10.2

F0011, G301,

ICD-10 Finland

+∞

10.2

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

10.2

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

10.2

F00, F03,

ICD-10 Finland

+∞

10.2

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

+∞

10.2

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

104.2

10.2

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

104.2

10.2

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

104.2

10.2

F41.1

ICD-10 Finland

Generalized anxiety disorder

10.6

10.1

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

10.1

147

785

L01BC06

ATC

capecitabine; oral

0.2

10.1

423

R51

ICD-10 Finland

Headache

3.2

10.0

116

T89

ICPC

Diabetes insulin dependent

3.2

10.0

116

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

9.9

180

2680

A02BC03

ATC

lansoprazole; oral

1.4

9.9

461

3249

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.3

9.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

9.8

254

1584

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

9.8

100

1752

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

9.7

396

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

9.6

208

L82

ICD-10 Finland

Seborrhoeic keratosis

0.5

9.6

102

1768

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.0

9.6

464

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

9.5

145

ZXY02

NOMESCO Finland

Neuropsychologist

52.1

9.4

N05CD08

ATC

midazolam; nasal, systemic

2.8

9.3

157

SPAT1243

SPAT

Psychiatric/psychological examination

12.6

9.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

9.3

278

K92.0

ICD-10 Finland

Haematemesis

2.5

9.3

218

Y94.0

ICD-10 Finland

Accident at home

3.5

9.2

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

94.6

9.2

F01.0

ICD-10 Finland

Vascular dementia of acute onset

94.6

9.2

I63.8

ICD-10 Finland

Other cerebral infarction

+∞

9.2

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

9.2

N03AX18

ATC

lacosamide; systemic

+∞

9.2

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

9.2

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

+∞

9.2

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

9.2

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

9.2

ACC53

NOMESCO Finland

Release of ulnar nerve

+∞

9.2

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

8.6

9.1

P15

ICPC

Chronic alcohol abuse

8.6

9.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

9.1

473

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

9.1

378

N99

ICPC

Neurological disease other

16.6

9.1

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

3.8

9.1

OAB93, ,

SPAT

3.6

9.0

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

9.0

591

4407

SCA02

NOMESCO Finland

Preventive oral health care

2.0

8.9

477

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

8.9

137

744

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

9.0

8.9

R33

ICD-10 Finland

Retention of urine

1.7

8.9

163

931

I95.9

ICD-10 Finland

Hypotension, unspecified

3.6

8.9

SPAT1014

SPAT

Treatment of eyes

3.1

8.9

110

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

4.7

8.8

R4130

NOMESCO Finland

Speech therapy

4.0

8.8

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

8.8

F99

ICD-10 Finland

Mental disorder, not otherwise specified

34.7

8.8

G04BD08

ATC

solifenacin; oral

2.0

8.7

101

500

SPAT1285

SPAT

Provision of consultation response

2.2

8.7

314

ZXD05

NOMESCO Finland

Urgent procedure

1.4

8.7

448

3203

AA1CG, ,

SPAT

9.5

8.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

8.6

548

4057

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

8.6

297

R54

ICD-10 Finland

Senility

4.9

8.6

-2, ,

ICPC

4.9

8.6

K86

ICPC

Hypertension uncomplicated

0.5

8.6

1398

KMAK, ,

NOMESCO Finland

1.4

8.6

559

4155

G51.0

ICD-10 Finland

Bell palsy

11.9

8.5

R06.5

ICD-10 Finland

Mouth breathing

2.5

8.5

199

G04CB01

ATC

finasteride; oral

1.5

8.4

243

1550

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

47.3

8.4

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

47.3

8.4

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

8.1

8.4

A99

ICPC

Disease/condition unspecnature/site

1.8

8.4

124

665

A10BB12

ATC

glimepiride; oral

1.7

8.4

166

967

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

3.4

8.3

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

8.3

246

3296

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

8.3

371

2586

K91

ICPC

Cerebrovascular disease

15.4

8.3

A04AA01

ATC

ondansetron; systemic, rectal

0.3

8.2

762

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

26.0

8.2

N04BC04

ATC

ropinirole; oral

85.2

8.2

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

85.2

8.2

G44.0

ICD-10 Finland

Cluster headache syndrome

85.2

8.2

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

85.2

8.2

XA400

NOMESCO Finland

EEG

18.9

8.2

Z75.0

ICD-10 Finland

Medical services not available in home

18.9

8.2

F32.8

ICD-10 Finland

Other depressive episodes

18.9

8.2

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

8.2

645

4931

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

9.5

8.2

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

+∞

8.1

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

8.1

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

+∞

8.1

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

8.1

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

8.1

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

8.1

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

8.1

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

8.1

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

+∞

8.1

N88

ICPC

Epilepsy

+∞

8.1

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

+∞

8.1

F0003, G300,

ICD-10 Finland

+∞

8.1

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

8.1

F31.8

ICD-10 Finland

Other bipolar affective disorders

+∞

8.1

F0002, G300,

ICD-10 Finland

+∞

8.1

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

8.1

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

8.1

R40.2

ICD-10 Finland

Coma, unspecified

6.5

8.1

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.1

8.1

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

8.1

159

926

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

8.0

267

1756

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.1

8.0

M01AX01

ATC

nabumetone; oral

2.2

7.9

283

M03BX01

ATC

baclofen; systemic

8.9

7.9

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

7.9

511

3785

K59.0

ICD-10 Finland

Constipation

2.0

7.9

437

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.0

7.9

N07BB01

ATC

disulfiram; oral

4.2

7.9

JN4AD

NOMESCO Finland

Body CT examination

0.4

7.8

903

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

16.2

7.8

N03AX11

ATC

topiramate; oral

11.1

7.8

Z03

ICPC

Housing/neighbourhood problem

11.1

7.8

P99

ICPC

Psychological disorders other

9.5

7.7

R25.1

ICD-10 Finland

Tremor, unspecified

3.3

7.7

SPAT1260

SPAT

Consultation of another employee

1.5

7.7

221

1409

A03FA02

ATC

cisapride; oral, rectal

1.7

7.7

130

727

R13

ICD-10 Finland

Dysphagia

2.0

7.6

377

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.0

7.6

105

ZXD35

NOMESCO Finland

Usual procedure

2.4

7.6

192

S18

ICPC

Laceration/cut

0.7

7.6

383

4672

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

7.6

226

1452

G25.0

ICD-10 Finland

Essential tremor

3.8

7.6

J01FA06

ATC

roxithromycin; oral

1.3

7.6

603

4608

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

7.5

165

2362

M01AB55

ATC

diclofenac, combinations; oral

1.8

7.5

115

625

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

14.2

7.4

N06AX18

ATC

reboxetine; oral

14.2

7.4

A05

ICPC

Feeling ill

2.4

7.4

206

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

7.4

180

1104

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.8

7.4

128

N05AC01

ATC

periciazine; systemic

17.4

7.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

17.4

7.4

M01AC06

ATC

meloxicam; systemic, rectal

1.4

7.3

489

3635

A02BC01

ATC

omeprazole; systemic

1.4

7.3

434

3168

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.2

7.3

349

Z08

ICPC

Social welfare problem

7.6

7.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

7.3

332

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.0

7.2

L57.0

ICD-10 Finland

Actinic keratosis

0.5

7.2

1454

SPAT1111

SPAT

Planning of analgesia

3.6

7.2

AXX01

NOMESCO Finland

Memory assessment

75.7

7.2

S06.9

ICD-10 Finland

Intracranial injury, unspecified

75.7

7.2

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

75.7

7.2

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

7.2

130

739

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.1

7.2

247

XF606

NOMESCO Finland

Ortostatic test

8.4

7.2

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

7.2

157

4359X

ICD-9 Finland

Transient cerebral ischaemia, Unspecified transient cerebral ischaemia

+∞

7.1

G40.89

ICD-10 Finland

Other epilepsy

+∞

7.1

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

7.1

F0009, G301,

ICD-10 Finland

+∞

7.1

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

+∞

7.1

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

7.1

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

+∞

7.1

Q90.9

ICD-10 Finland

Down syndrome, unspecified

+∞

7.1

N05AL01

ATC

sulpiride; systemic

6.1

7.0

J01XX05

ATC

methenamine; oral

3.0

7.0

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

4.3

7.0

K08.3

ICD-10 Finland

Retained dental root

1.8

7.0

498

A10AD05

ATC

insulin aspart; parenteral

2.4

6.9

183

M02AA10

ATC

ketoprofen; topical

1.5

6.9

227

1487

P04

ICPC

Feeling/behaving irritable/angry

28.4

6.9

F10.24

ICD-10 Finland

Alcohol depence active use

28.4

6.9

Z60.8

ICD-10 Finland

Other problems related to social environment

28.4

6.9

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

6.9

166

1016

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

6.9

411

A02BC05

ATC

esomeprazole; systemic

1.3

6.9

529

4010

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

6.9

111

612

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

6.9

136

794

M02AA07

ATC

piroxicam; topical

1.3

6.8

597

4612

P05

ICPC

Senility, feeling/behaving old

6.2

6.8

PA7BD

NOMESCO Finland

CT angiography of neck and brain

8.3

6.8

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.2

6.8

294

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.4

6.7

J01DA09

ATC

[U] cefadroxil

1.4

6.7

358

2566

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.6

542

4143

K03.66

ICD-10 Finland

Tooth plaque

1.9

6.6

397

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

6.6

351

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

37.8

6.6

Z74.1

ICD-10 Finland

Need for assistance with personal care

37.8

6.6

F10.25

ICD-10 Finland

Alcohol dependence continuous use

37.8

6.6

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

15.8

6.5

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

15.8

6.5

SPAT1125

SPAT

Stoma care and guidance

2.6

6.5

137

SPAT1153

SPAT

Removal of sutures

0.7

6.4

247

3166

W18

ICD-10 Finland

Other fall on same level

5.8

6.4

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

6.4

122

705

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.2

6.4

323

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

6.4

124

720

SPAT1138

SPAT

Guidance concerning bowel function

3.1

6.4

WZC30

NOMESCO Finland

Teaching

0.5

6.4

1285

N06AB08

ATC

fluvoxamine; oral

3.3

6.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

6.3

379

2767

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

3.1

6.3

F06.0

ICD-10 Finland

Organic hallucinosis

66.0

6.3

G72.9

ICD-10 Finland

Myopathy, unspecified

66.0

6.3

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

66.0

6.3

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

66.0

6.3

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

6.2

242

C03CA01

ATC

furosemide; systemic

1.3

6.2

730

5845

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

6.2

313

N06AX22

ATC

agomelatine; oral

13.5

6.2

F32.0

ICD-10 Finland

Mild depressive episode

4.0

6.2

M01AH01

ATC

celecoxib; oral

1.4

6.1

244

1660

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

6.1

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

+∞

6.1

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

+∞

6.1

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

+∞

6.1

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

6.1

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

+∞

6.1

F30.9

ICD-10 Finland

Manic episode, unspecified

+∞

6.1

35701

ICD-8 Finland

Other diseases of peripheral nerves except autonomic, Nervi mediani

+∞

6.1

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

+∞

6.1

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

+∞

6.1

F002, G308,

ICD-10 Finland

+∞

6.1

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

+∞

6.1

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

+∞

6.1

N05BA09

ATC

clobazam; oral

+∞

6.1

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

+∞

6.1

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

6.1

F0010, G300,

ICD-10 Finland

+∞

6.1

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

+∞

6.1

F0019, G300,

ICD-10 Finland

+∞

6.1

WX723

NOMESCO Finland

CPAP therapy

+∞

6.1

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

6.1

F009, G300,

ICD-10 Finland

+∞

6.1

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

+∞

6.1

F0024, G308,

ICD-10 Finland

+∞

6.1

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

+∞

6.1

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

+∞

6.1

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

6.1

G41.0

ICD-10 Finland

Grand mal status epilepticus

+∞

6.1

F0023, G308,

ICD-10 Finland

+∞

6.1

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

6.1

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

5.0

6.1

C05AA08

ATC

fluocortolone; rectal, topical

1.5

6.1

181

1163

R40.0

ICD-10 Finland

Somnolence

17.0

6.1

3639

FHL

Other measure in this category

7.7

6.1

P27

ICPC

Fear of mental disorder

25.2

6.0

F43.29

ICD-10 Finland

Adaptation disorder UNS

8.7

6.0

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

8.7

6.0

WW200, ,

SPAT

0.6

6.0

141

1990

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

224

65.84

307.65

1.2

124.42

47.68

e6/l

1.25

179

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

224

65.84

307.65

1.1

2.26

17.75

e6/l

0.54

171

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

227

54.66

307.65

1.1

3.75

3.62

mmol/l

0.53

216

(3044290) Cell count panel - Cerebral spinal fluid

180

44.24

286.77

1.1

—

(3023410) Appearance of Cerebral spinal fluid

104

86.03

186.64

1.2

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

31.42

108.24

1.1

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

553

2143

2.97

93.35

1.8

1.7

1203.53

1129.71

nmol/l

1.07

397

1561

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

29.54

66.00

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

859

10734

0.57

32.27

3.9

4.2

1.50

mmol/l

0.13

749

9502

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

874

10857

0.57

31.94

3.9

4.2

4.56

4.64

mmol/l

1.27

771

9702

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

914

11185

0.58

31.10

4.3

4.7

2.66

2.72

mmol/l

1.10

797

9914

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

435

2346

1.95

30.31

1.7

445.81

17631582.97

pmol/l

1.25

357

1849

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

828

10353

0.58

29.99

3.5

3.8

1.20

1.24

mmol/l

1.05

711

9078

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

445

2482

1.88

27.74

2.5

1.7

281.16

180.63

u/l

1.96

406

2231

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

704

4621

1.67

24.46

2.1

1.9

96.86

92.07

pmol/l

1.62

351

2238

(40768804) Tissue Pathology biopsy report

297

4578

0.54

20.53

1.9

2.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

633

4196

1.61

20.32

4.1

3.6

62.42

73.65

ng/l

0.31

459

3163

(3015377) Calcium [Moles/volume] in Serum or Plasma

576

3743

1.63

19.99

2.1

3.6

2.35

mmol/l

0.57

472

3176

(3021960) Folate [Moles/volume] in Serum or Plasma

409

2452

1.72

19.23

1.5

20.33

19.87

nmol/l

0.24

353

2026

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

131

539

2.38

17.95

1.5

1.4

1.64

1.39

2.31

110

460

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

363

2149

1.72

17.73

2.4

3.2

2.44

2.47

mmol/l

7.53

288

1810

(3019150) Specific gravity of Urine by Refractometry

377

2267

1.70

17.36

5.4

3.8

1.02

kg/l

0.73

377

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

29.91

16.53

1.5

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

943

10694

0.68

15.62

15.4

14.0

73.35

70.78

ml/min/173m2

3.00

708

8681

(3023183) Ammonium ion [Moles/volume] in Plasma

123

3.74

15.27

1.7

2.6

31.24

36.84

umol/l

0.51

106

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

5.64

15.23

1.0

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

981

11010

0.69

15.07

4.2

4.5

6.20

6.01

mmol/l

2.31

842

9651

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

11.13

14.94

1.4

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

254

1428

1.77

14.72

8.6

7.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

959

7323

1.45

14.39

5.7

4.2

2024.35

2816.63

e6/l

0.22

113

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

15.64

14.25

1.0

—

(1761868) Lipid panel - Serum or Plasma

225

3433

0.57

14.08

3.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

13.31

12.29

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

129

616

2.04

12.28

1.6

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

+∞

12.23

14.2

0.0

718.50

—

nmol/l

—

(40761535) Cells panel - Urine sediment

172

909

1.86

12.16

3.7

3.0

—

(4035726) Immunohistochemistry procedure

1194

0.36

11.95

1.3

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

665

4871

1.43

11.85

3.4

4.4

34.88

34.14

g/l

2.39

575

4423

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

932

10330

0.72

11.58

5.9

5.7

42.44

40.48

mmol/mol

4.72

795

9228

(3019832) Treponema pallidum Ab [Presence] in Serum

168

2.97

11.56

1.1

1.2

—

(3026008) Bacteria identified in Urine by Culture

532

3755

1.46

11.53

3.7

3.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

270

3758

0.63

11.33

3.3

3.6

7.02

8.41

mg/mmol

0.23

165

2311

(3012516) Albumin [Mass/volume] in Urine

246

3492

0.62

11.23

2.8

3.1

50.27

278.77

mg/l

3.03

153

2153

(3023368) Bacteria identified in Blood by Culture

478

3320

1.47

11.22

3.8

3.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.88

11.19

1.1

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

176

2696

0.58

10.87

1.5

1.6

1.28

mmol/l

0.03

150

2189

(3021589) Normoblasts [#/volume] in Blood

380

4864

0.67

10.54

8.5

9.0

0.00

e9/l

0.26

294

3887

(3002256) Pathology report gross observation

1632

0.48

10.46

1.3

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

256

3524

0.64

10.06

2.6

2.9

7.14

6.90

mmol/l

0.42

192

2844

(3018677) aPTT in Platelet poor plasma by Coagulation assay

221

1334

1.63

9.74

1.6

2.0

29.51

30.63

1.95

212

1285

(3029937) Albumin [Presence] in Urine by Test strip

404

2786

1.46

9.68

5.1

3.8

0.00

estimate

0.50

874

(3003694) ABO and Rh group [Type] in Blood

196

2840

0.61

9.60

1.2

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

285

1834

1.54

9.55

1.8

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

15.80

9.54

1.2

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

11.52

9.48

1.1

127.65

145.07

nmol/l

0.40

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

420

5181

0.70

9.27

2.3

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

727

5598

1.35

8.98

4.9

6.0

1.22

1.21

mmol/l

5.02

604

4686

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1328

0.47

8.90

1.2

6.02

18.62

u/ml

2.29

466

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

321

2.18

8.67

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.43

8.51

2.6

2.2

—

(3002385) Erythrocyte distribution width [Ratio]

873

9507

0.76

8.10

19.1

17.2

15.22

15.12

0.21

829

9233

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1552

0.54

7.71

2.2

4.2

16.13

24.23

ug/l

0.31

1305

(3044889) 12 lead EKG panel

730

8107

0.76

7.66

3.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1149

12012

0.77

7.50

7.9

9.6

22.97

24.33

u/l

1.06

1051

11361

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

167

1006

1.61

7.42

2.6

2.3

6.82

6.81

ug/l

0.00

112

852

(3014271) Vancomycin [Susceptibility]

3.73

7.17

3.4

2.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

134

776

1.67

6.96

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.47

6.75

1.1

1.0

—

(3015736) pH of Urine

543

4144

1.32

6.73

4.4

3.3

5.82

5.83

0.01

212

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

200

1285

1.52

6.72

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

644

5037

1.30

6.66

4.6

5.3

1.22

1.21

mmol/l

2.10

552

4532

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1429

0.56

6.63

1.2

19.88

43.73

iu/ml

2.65

464

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

532

4058

1.32

6.60

5.0

3.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1518

0.58

6.56

2.3

3.8

245.46

255.18

u/l

0.38

1419

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

8.79

6.51

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

8.79

6.51

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

269

2.10

6.48

2.0

2.4

1452.82

364.94

ug/l

1.12

259

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

197

1273

1.51

6.44

1.7

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.21

6.28

1.1

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

340

2445

1.37

6.21

5.0

3.3

—

(3028707) Methadone [Presence] in Urine by Screen method

13.51

6.17

1.2

1.0

—

(3018010) Neutrophils/100 leukocytes in Blood

422

4933

0.75

6.07

5.1

5.4

59.94

58.82

0.99

375

4516

(3006270) Folate [Moles/volume] in Blood

2.88

5.92

1.1

358.81

333.73

nmol/l

0.23

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

8.11

5.80

1.1

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1146

0.55

5.65

1.2

1.3

—

(3000492) Spirometry study

814

0.47

5.58

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

188

2468

0.69

5.55

2.7

3.2

0.98

0.92

ug/l

0.13

129

1746

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

533

4168

1.28

5.31

1.9

2.0

77.84

80.47

nmol/l

1.09

431

3603

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

6.16

5.29

1.0

—

(3022096) Basophils/100 leukocytes in Blood

413

4762

0.77

5.22

4.6

5.4

0.63

0.65

0.33

363

4346

(3002030) Lymphocytes/100 leukocytes in Blood

441

5040

0.77

5.20

5.0

5.6

25.37

25.86

0.39

390

4625

(40760892) CBC W Ordered Manual Differential panel - Blood

415

4770

0.77

5.10

4.5

5.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

236

2938

0.72

5.09

2.1

2.7

2852.48

7877.72

umol/l

1.79

192

2476

(3006504) Eosinophils/100 leukocytes in Blood

428

4896

0.78

5.06

4.9

5.4

2.80

2.83

0.08

378

4471

(3037522) Nuclear Ab [Titer] in Serum

1058

0.56

4.97

1.2

515.56

517.93

titre

—

232

(3019198) Lymphocytes [#/volume] in Blood

470

5301

0.78

4.93

5.2

1.71

1.83

e9/l

1.84

389

4540

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

12.60

4.90

1.1

1.0

—

(3019069) Monocytes/100 leukocytes in Blood

432

4916

0.78

4.87

5.4

5.7

8.62

8.92

0.88

385

4493

(1001926) Buprenorphine [Presence] in Urine by Screen method

5.13

4.66

1.2

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

7.27

4.64

2.8

1.7

39190.00

26222.15

ug/l

—

(3001604) Monocytes [#/volume] in Blood

458

5151

0.79

4.64

5.1

0.58

0.62

e9/l

2.23

377

4280

(3009343) pH of Capillary blood

534

1.63

4.59

2.4

3.9

7.43

7.40

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

566

6203

0.80

4.53

7.0

8.4

4.47

4.29

e9/l

0.87

472

5269

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

13.22

4.42

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

13.22

4.42

1.1

1.0

—

(3013115) Eosinophils [#/volume] in Blood

479

5331

0.80

4.38

5.2

0.18

0.20

e9/l

1.13

391

4492

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

541

1.61

4.37

2.4

3.9

5.16

5.11

kpa

0.29

504

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

312

1.80

4.33

2.6

4.1

24.27

24.41

mmol/l

0.14

269

(3006315) Basophils [#/volume] in Blood

463

5165

0.80

4.31

5.1

0.04

e9/l

2.25

380

4287

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

221

2707

0.74

4.25

2.1

2.4

—

(3035350) Ketones [Presence] in Urine by Test strip

638

5217

1.22

4.10

4.6

3.6

0.00

estimate

0.50

1033

(3013826) Glucose [Moles/volume] in Serum or Plasma

763

6352

1.21

4.09

4.4

3.9

7.17

6.85

mmol/l

2.44

690

5928

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

513

1.60

4.09

2.4

3.8

1.10

1.81

mmol/l

1.03

363

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

644

0.50

4.07

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

314

3622

0.78

3.84

2.1

2.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

113

2.27

3.77

30.0

6.9

7.90

7.11

mmol/l

0.56

(3022217) INR in Platelet poor plasma by Coagulation assay

672

5570

1.20

3.69

15.9

18.6

1.33

1.49

inr

1.40

156

1510

(3022313) Gas panel - Capillary blood

387

1.65

3.65

2.4

3.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

405

0.41

3.64

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.98

3.63

1.2

1.0

1726.90

1931.63

miu/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

236

0.32

3.58

1.9

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

185

0.25

3.55

3.0

4.5

—

407.00

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

148

1875

0.72

3.54

3.0

2.8

3.17

2.85

e6/l

0.15

1071

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

283

1.75

3.53

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

283

1.75

3.53

1.5

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.91

3.48

1.0

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

129

1666

0.71

3.47

2.1

2.4

21.55

21.27

0.08

1421

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

407

3228

1.24

3.44

2.2

2.3

58.70

63.55

u/l

0.57

366

2952

(3002179) Metamyelocytes/100 leukocytes in Blood

809

0.59

3.43

2.3

3.8

0.86

0.71

0.08

281

(3017181) Myelocytes/100 leukocytes in Blood

901

0.62

3.43

2.5

3.8

2.24

0.95

0.45

325

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

7.34

3.41

2.6

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

7.34

3.41

2.6

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

631

5244

1.19

3.30

6.0

5.0

0.00

estimate

-0.00

916

(3016879) Cocaine [Presence] in Urine

3.07

3.27

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

864

0.62

3.22

2.6

3.8

0.12

0.11

0.02

291

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

417

1.58

3.18

1.9

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

432

0.47

3.16

1.1

1.8

—

20.22

—

(21494755) Public health laboratory ask at order entry panel

519

0.52

3.16

1.2

1.4

—

(40768441) Liver Pathology biopsy report

0.00

3.15

0.0

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

885

7597

1.17

3.11

4.7

4.1

—

(3025159) Blasts/100 leukocytes in Blood

788

0.61

3.11

2.6

3.9

0.08

0.14

0.23

236

(3009261) Glucose [Presence] in Urine by Test strip

635

5309

1.19

3.06

4.7

3.6

0.00

estimate

0.50

927

(3000764) Benzodiazepines [Presence] in Urine

2.82

3.06

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1077

0.67

3.05

4.2

5.5

12.53

12.54

mmol/l

0.00

998

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.34

2.98

1.3

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

530

0.54

2.93

1.9

1.8

1.96

1.44

g/l

0.39

462

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

7.08

2.93

1.0

—

(3028300) Cannabinoids [Presence] in Urine

2.70

2.85

1.2

—

(3027008) Opiates [Presence] in Urine

2.70

2.85

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.58

2.81

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

143

1753

0.75

2.78

1.9

2.3

2.19

2.24

g/l

0.48

115

1601

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

381

4166

0.83

2.75

4.0

5.3

3.57

5.98

ug/l

1.58

325

3662

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

466

1.49

2.68

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

175

0.32

2.68

1.2

1.8

2.35

5.00

mmol/24h

—

143

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

163

1951

0.77

2.67

2.7

1.71

1.29

e6/l

0.75

1141

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.20

2.64

1.0

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

118

1462

0.75

2.49

4.0

4.7

1.04

1.06

mmol/l

0.30

102

1329

(3022145) Colonoscopy Study observation

1109

0.71

2.49

1.2

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

332

0.48

2.47

1.2

1.7

—

133.33

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.40

2.46

1.5

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

6.74

2.44

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

830

0.67

2.43

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.15

2.42

1.0

—

(3027944) Amphetamines [Presence] in Urine

2.56

2.42

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

109

766

1.36

2.39

1.4

—

(3019225) pH of Specimen

148

1090

1.30

2.36

4.4

4.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

319

1.55

2.33

3.6

3.2

35.62

28.59

mg/l

0.48

212

(3024891) Influenza virus A+B Ag [Presence] in Specimen

253

1.61

2.29

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

146

0.32

2.29

1.0

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

290

3199

0.83

2.29

3.2

3.1

0.58

0.62

e6/l

0.11

233

2429

(3011288) Drugs identified in Urine by Screen method

3.89

2.23

1.7

1.3

—

(3018418) pH of Serum or Plasma

405

3342

1.18

2.22

2.5

3.9

7.41

7.40

0.63

613

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

240

0.43

2.18

1.1

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

657

1.36

2.16

1.6

2.4

415.24

397.55

nmol/l

0.33

601

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

159

0.35

2.14

1.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

324

0.52

2.10

1.6

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1026

0.73

2.02

1.8

2.5

65.42

65.55

g/l

0.05

907

(4281824) Cell count and differential, peritoneal fluid

152

0.37

2.02

1.8

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

863

0.71

2.01

2.9

2.6

64.67

57.03

ml/min/173m2

1.06

370

(3037756) Immunofixation for Serum or Plasma

292

0.51

1.96

1.7

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

127

1504

0.78

1.96

1.5

2.63

2.72

g/l

0.17

844

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

973

0.74

1.91

1.7

2.1

0.19

0.20

g/l

0.38

901

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

420

0.60

1.91

4.0

2.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

613

0.67

1.90

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

250

0.49

1.87

1.2

1.1

—

(3005570) Glucose [Moles/volume] in Urine

114

1.83

1.87

1.8

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

641

0.68

1.83

3.2

6.5

24.87

24.90

mmol/l

0.02

635

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

235

0.48

1.83

1.6

111.08

262.41

pmol/l

1.78

227

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

296

0.54

1.82

1.1

3.1

16.61

988.13

u/ml

1.44

277

(3022948) Iron [Moles/volume] in Serum or Plasma

164

1867

0.81

1.80

1.9

2.3

11.82

11.85

umol/l

0.01

132

1726

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

649

0.69

1.79

1.3

1.6

1.58

1.52

g/l

0.14

550

(3020891) Body temperature

412

1.41

1.77

5.8

3.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

129

0.36

1.76

1.2

1.3

0.39

0.74

g/l

—

(40768795) Lymph node Pathology biopsy report

130

0.36

1.75

1.0

1.1

—

(40768793) Breast Pathology biopsy report

268

0.52

1.75

1.1

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

474

0.65

1.69

1.2

2.2

3.96

3.66

g/l

0.67

413

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

451

0.64

1.68

1.3

2.1

10.72

10.71

g/l

0.01

383

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

381

0.61

1.66

1.3

2.0

38.51

36.85

g/l

0.76

318

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

154

1196

1.23

1.65

3.9

3.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.42

1.63

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.42

1.63

1.9

—

(3013512) EKG study

338

3579

0.87

1.62

4.0

3.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

272

0.55

1.61

1.1

1.4

—

11.91

—

(3000850) Epithelial cells [#/volume] in Urine

290

2396

1.16

1.58

2.7

2.5

6.28

5.82

e6/l

0.23

257

2098

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

609

0.70

1.56

8.6

8.1

—

(3012441) Differential panel - Pleural fluid

196

0.48

1.56

1.7

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

0.67

1.56

1.2

2.2

7.74

7.55

g/l

0.21

417

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

149

0.44

1.55

2.3

3.5

2.70

48.43

nmol/l

—

144

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

475

0.67

1.54

1.2

2.2

—

(3051593) INR in Capillary blood by Coagulation assay

2.25

1.53

5.4

40.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

440

0.66

1.52

1.3

2.3

3.02

3.16

g/l

0.30

379

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

0.39

1.50

1.2

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

346

0.62

1.47

2.3

3.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

287

0.59

1.46

1.1

1.2

—

(3007461) Platelets [#/volume] in Blood

1275

12457

0.90

1.45

23.1

20.5

242.66

243.17

e9/l

0.10

1178

11925

(3000963) Hemoglobin [Mass/volume] in Blood

1276

12463

0.90

1.44

23.1

20.7

129.65

132.25

g/l

7.56

1192

12139

(3026361) Erythrocytes [#/volume] in Blood

1276

12460

0.90

1.42

23.0

20.5

4.30

4.38

e12/l

6.75

1169

11878

(3035941) MCH [Entitic mass]

1276

12458

0.90

1.41

22.9

20.5

30.31

30.37

0.56

1195

12127

(40768806) Pleura Pathology biopsy report

188

0.50

1.41

1.7

1.5

—

(3024731) MCV [Entitic volume]

1276

12457

0.90

1.41

23.0

20.5

91.48

91.67

0.75

1196

12126

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

168

0.50

1.40

2.1

2.0

12.04

22.27

ug/l

—

161

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

319

3355

0.88

1.39

4.0

4.4

20.61

22.36

1.48

152

1826

(3024354) Oxygen [Partial pressure] in Venous blood

117

903

1.23

1.37

2.4

2.7

4.18

4.28

kpa

0.22

107

861

(3010813) Leukocytes [#/volume] in Blood

1277

12457

0.91

1.36

23.1

20.5

7.06

6.82

e9/l

2.31

1171

11871

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

353

2992

1.13

1.36

2.1

2.2

3.19

3.15

mg/l

0.10

274

2493

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

1.35

0.0

1.4

—

(3000330) Specific gravity of Urine by Test strip

708

0.75

1.33

4.0

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

359

0.65

1.33

1.6

44.15

38.43

u/l

0.75

305

(3009542) Hematocrit [Volume Fraction] of Blood

1276

12441

0.91

1.33

23.0

20.7

38.05

39.03

4.02

1113

11400

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

694

1.26

1.32

1.7

1.6

—

(36304419) Bacteria [Presence] in Urine

292

3077

0.88

1.31

3.1

3.0

—

(40768800) Prostate Pathology biopsy report

312

0.63

1.30

1.3

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

100

1153

0.81

1.30

2.0

2.7

10.83

10.66

umol/l

0.02

997

(3044941) Cell count panel - Synovial fluid

162

0.52

1.30

1.7

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

194

0.53

1.29

1.0

1.3

—

364.00

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1217

11034

1.10

1.28

16.9

14.0

31.49

28.75

mg/l

1.32

966

8641

(3032057) Clostridioides difficile [Presence] in Stool

2.77

1.27

1.6

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

113

0.42

1.24

1.6

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

190

0.54

1.22

1.2

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.16

1.20

1.5

2.6

—

(3045142) Bone marrow Pathology biopsy report

137

0.48

1.20

1.6

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.62

1.20

1.2

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

0.53

1.19

1.1

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

470

0.72

1.19

1.2

1.1

56.99

146.60

iu/ml

1.97

154

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

1.16

0.0

2.9

—

4912.20

—

(3045788) Cell count panel - Pleural fluid

175

0.54

1.16

2.0

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

402

0.70

1.15

1.6

1.2

—

(40758558) Short blood count panel - Blood

264

2774

0.88

1.15

5.3

6.4

—

(40761511) CBC panel - Blood by Automated count

1181

11518

0.92

1.14

16.3

13.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

1.14

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.00

1.14

0.0

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

455

0.72

1.13

2.4

2.5

0.35

0.33

u/ml

0.17

251

(3012095) Magnesium [Moles/volume] in Serum or Plasma

153

1667

0.85

1.11

2.2

2.9

0.83

0.82

mmol/l

0.80

136

1522

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

122

1354

0.84

1.10

4.3

4.2

33.99

33.61

0.14

801

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

261

1.38

1.09

1.2

1.1

—

(3000012) Reticulocyte production index

194

0.58

1.08

1.5

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.36

1.07

1.4

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

608

0.77

1.05

5.4

7.9

24.73

24.32

mmol/l

0.46

576

(3014765) Yersinia sp identified in Stool by Organism specific culture

263

1.37

1.05

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

137

1.52

1.04

2.0

1.83

1.51

u/field

—

(42529406) Shigella sp [Presence] in Stool by Culture

265

1.36

1.01

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

178

0.58

1.00

1.7

2.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

855

7689

1.08

1.00

3.4

3.5

15.13

15.10

pmol/l

0.08

731

6723

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.89

1.00

1.1

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.89

1.00

1.1

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

128

0.51

0.98

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

200

0.61

0.98

1.8

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.98

0.0

1.2

—

147.54

—

(3023520) Reticulocytes [#/volume] in Blood

1104

0.84

0.97

1.9

2.4

62.62

65.80

e9/l

0.48

827

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

186

0.61

0.94

1.3

2.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

134

0.56

0.93

1.3

2.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

137

0.55

0.93

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

2.18

0.92

1.2

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

263

0.68

0.91

1.4

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.76

0.91

1.9

1.7

0.17

4.54

u/field

—

(3007853) Bacteria identified in Skin by Aerobe culture

138

1132

1.16

0.90

1.5

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

922

0.83

0.89

1.4

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

1.42

0.89

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

146

0.58

0.88

1.6

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

121

0.54

0.88

1.3

1.2

—

(21494434) Karyotype in Bone marrow

123

0.53

0.88

1.4

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

795

0.82

0.85

1.8

2.4

—

(1002224) Polysomnography panel

113

1.50

0.85

1.1

1.0

—

(3008898) HLA-B27 [Presence]

167

0.62

0.81

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

245

0.69

0.81

1.4

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

202

2105

0.89

0.81

1.5

1.78

1.63

mg/l

0.10

138

1618

(3000285) Sodium [Moles/volume] in Blood

0.00

0.79

0.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.1

—

(3024932) HLA-DR beta [Type]

0.00

0.79

0.0

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.79

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

199

0.66

0.78

1.1

1.2

—

121.25

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.78

0.0

1.2

—

16.11

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.51

0.78

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.51

0.78

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.51

0.78

1.4

1.6

—

(40768443) Skin Pathology biopsy report

487

0.79

0.77

1.2

1.3

—

(3002032) Base excess in Venous blood by calculation

132

1096

1.14

0.76

2.5

3.3

1.95

2.06

mmol/l

0.12

108

867

(3000570) Elastase.pancreatic [Mass/mass] in Stool

254

1.30

0.76

1.2

1.4

294.64

269.46

ug/g

0.33

152

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

175

0.64

0.76

1.4

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

207

0.68

0.74

1.1

1.2

—

1468.33

—

(3008295) Osmolality of Serum or Plasma

1.54

0.73

1.3

281.60

274.52

mosm/kgh2o

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

162

0.64

0.73

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

264

2694

0.91

0.72

3.1

3.6

85.82

84.30

0.38

251

2628

(3021447) Carbon dioxide [Partial pressure] in Venous blood

131

1096

1.13

0.69

2.5

3.3

5.80

kpa

0.01

122

1048

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

111

1.45

0.69

4.4

2.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

159

0.65

0.68

1.3

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

110

0.60

0.68

1.4

1.6

12.00

14.68

u/l

—

105

(3051651) Icteric interference index of Serum or Plasma

1.60

0.68

4.8

3.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

257

0.73

0.68

1.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

672

0.84

0.67

2.1

2.5

—

(3042936) Bacteria identified in Isolate by Culture

147

1537

0.89

0.65

1.9

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1.57

0.64

1.2

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

703

1.16

0.64

9.4

5.3

24.70

24.17

mmol/l

0.67

664

(3014111) Lactate [Moles/volume] in Serum or Plasma

116

969

1.14

0.64

3.6

5.9

1.62

1.39

mmol/l

1.25

108

933

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.53

0.63

1.1

—

(40761536) Microorganisms panel - Urine sediment

918

0.87

0.63

4.4

3.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

805

7844

0.94

0.62

3.4

3.7

13.53

15.64

mm/h

3.30

706

7026

(3000093) Morphology [Interpretation] in Blood Narrative

0.58

0.62

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.68

0.62

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

129

0.66

0.61

1.2

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

397

3952

0.93

0.60

2.9

3.0

2216.59

2259.26

ng/l

0.05

317

3423

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.60

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.00

0.60

0.0

1.2

—

(36660697) Celiac disease serology panel - Serum

562

0.83

0.60

1.1

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

641

0.85

0.58

1.8

2.8

10.18

10.74

g/l

0.60

577

(3052851) Hemolysis interference index of Serum or Plasma

351

1.21

0.58

4.3

3.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

206

0.73

0.57

2.1

4.0

0.77

1.39

0.57

166

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.57

0.56

1.0

1.3

170.00

267.71

pmol/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

205

0.73

0.55

3.3

3.4

59.50

59.27

0.04

205

(3001019) Free T4 and TSH panel - Serum or Plasma

258

0.76

0.55

1.2

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

866

0.88

0.54

2.8

3.5

89.33

97.39

ng/l

0.27

723

(3017732) Neutrophils [#/volume] in Blood

654

0.86

0.52

3.6

2.8

4.72

6.03

e9/l

0.63

492

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

192

0.73

0.52

1.5

1.6

1.73

4.80

iu/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

317

0.80

0.51

1.6

1.5

—

(3035880) pH of Pleural fluid

103

0.64

0.48

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

312

3104

0.94

0.48

2.5

2.9

36.05

37.30

u/l

0.11

287

2906

(1761482) Bacteria [#/volume] in Urine by Culture

456

0.84

0.47

4.2

4.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

486

0.85

0.47

1.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

565

0.86

0.45

2.2

1.9

11.36

11.48

nmol/l

0.04

493

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

494

1.15

0.45

2.3

1.8

1.36

3.00

ug/l

0.92

424

(3017143) Hepatitis C virus Ab [Presence] in Serum

674

0.88

0.45

1.6

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

165

0.74

0.44

1.4

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

165

0.74

0.44

1.4

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

463

0.85

0.44

3.0

3.1

4.28

4.43

pmol/l

0.43

408

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.42

0.44

1.1

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

106

1.34

0.43

1.2

1.3

—

(3045414) Leukocytes [Presence] in Urine

411

0.85

0.43

2.4

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.64

0.42

1.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.63

0.42

1.0

1.2

—

(3012544) pH of Venous blood

131

1136

1.09

0.42

2.4

3.4

—

7.41

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

205

0.78

0.42

1.1

1.2

3.32

3.59

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.3

—

41.18

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.41

0.0

2.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

0.73

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

5.1

—

(3024928) Oxygen saturation in Venous blood

235

0.80

0.40

1.4

2.7

—

(3022621) pH of Urine by Test strip

786

1.11

0.40

4.0

3.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.40

0.0

5.9

—

5.51

—

(3021901) Oxygen saturation in Capillary blood

184

1.23

0.39

2.0

3.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.2

—

0.31

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.38

0.39

1.1

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.39

0.38

1.4

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.39

0.38

1.0

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.39

0.38

1.0

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

139

0.74

0.38

1.2

—

20.33

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

232

0.81

0.37

1.1

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

712

0.90

0.37

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

503

0.88

0.36

2.4

2.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

127

0.74

0.36

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

478

1.13

0.35

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

115

0.74

0.35

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

127

1.26

0.35

1.1

1.4

—

(4146454) Self-monitoring of blood glucose

126

0.75

0.34

2.8

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

526

4806

1.04

0.34

2.5

2.1

—

(4200892) Spirometry reversibility

627

0.90

0.32

1.5

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

119

1203

0.93

0.32

2.5

2.7

236.77

335.74

ng/l

1.67

1081

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.29

0.32

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

135

0.77

0.32

1.9

1.4

—

(1616796) Gas panel - Central venous blood

233

1.17

0.32

2.1

4.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

228

2252

0.95

0.31

3.4

3.6

289.97

622.73

ng/l

1.27

182

1951

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.35

0.31

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.72

0.31

1.0

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.71

0.31

1.3

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

422

4102

0.96

0.30

2.5

2.6

131.18

165.11

ug/l

2.54

353

3677

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

276

0.85

0.30

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

0.82

0.30

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

165

1.20

0.29

1.4

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

643

5918

1.03

0.28

2.9

2.6

45.85

55.11

u/l

2.27

570

5289

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

952

0.93

0.28

2.3

3.5

1.23

mmol/l

0.18

817

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

123

1.23

0.27

1.1

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

123

1.23

0.27

1.1

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

123

1.23

0.27

1.1

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.26

0.27

1.1

1.6

—

(3044927) Protein electrophoresis panel - Urine

121

0.78

0.27

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

323

0.87

0.27

2.1

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

939

0.93

0.26

1.9

2.2

82.49

36.42

u/l

0.38

800

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

606

5836

0.97

0.26

3.7

6.0

12.49

12.78

umol/l

0.18

543

5504

(3017704) Immunofixation for Urine

0.69

0.26

1.4

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

150

1489

0.94

0.26

2.0

2.3

1.66

1.72

0.24

117

1307

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

124

1.22

0.26

1.1

1.4

—

(3016502) Oxygen saturation in Arterial blood

116

1159

0.94

0.25

6.2

6.1

94.37

95.14

0.47

110

1106

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.18

0.24

2.0

1.7

72.89

90.36

umol/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

183

1648

1.05

0.24

1.2

2.49

2.14

u/ml

0.08

404

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.35

0.23

2.2

2.0

—

(3003338) MCHC [Mass/volume]

985

9152

1.03

0.23

20.9

18.8

330.65

330.69

g/l

0.04

928

9022

(3024522) Salmonella sp identified in Specimen by Organism specific culture

126

1.20

0.23

1.1

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.0

—

25.97

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

9.38

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

8.6

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

22.55

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

36.67

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.18

0.21

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.18

0.21

1.0

—

(3023419) Bacteria identified in Sputum by Culture

147

0.83

0.21

1.9

2.7

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.37

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

146

0.84

0.20

1.2

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.20

0.19

1.0

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

917

8745

0.98

0.19

4.8

7.0

80.38

85.04

u/l

1.74

817

8072

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.18

0.19

1.2

1.1

—

(3000991) Gas panel - Venous blood

954

0.95

0.19

3.8

7.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.15

0.19

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.15

0.19

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.15

0.19

1.2

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

366

3531

0.97

0.19

3.2

3.1

87.70

174.37

e6/l

1.14

290

2696

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

175

0.86

0.19

1.1

1.2

—

(40768797) Stomach Pathology biopsy report

132

1299

0.95

0.19

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

1.20

0.18

1.4

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

273

0.90

0.18

3.0

2.7

—

(40767503) Oxygen content in Capillary blood by calculation

213

0.88

0.17

2.2

2.5

16.39

15.15

—

(3026470) Cobalt [Mass/volume] in Blood

1.12

0.17

1.4

1.9

1.04

4.65

ug/l

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

704

1.06

0.17

2.5

2.8

126.92

124.63

g/l

0.51

681

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.76

0.17

1.6

2.0

—

(3021788) Differential panel - Synovial fluid

173

0.87

0.16

1.7

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

366

1.08

0.16

1.2

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

192

0.88

0.16

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

167

1.13

0.16

1.4

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.76

0.15

1.0

1.1

—

(3026782) Osmolality of Urine

253

2442

0.97

0.14

3.0

2.9

569.01

540.26

mosm/kgh2o

1.29

206

2055

(3003740) Influenza virus B Ag [Presence] in Specimen

0.81

0.14

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.81

0.14

1.0

1.1

—

(3018095) Leukocytes [#/volume] in Urine

435

4027

1.02

0.14

3.8

3.5

372.67

189.68

e6/l

0.59

312

2880

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

121

0.86

0.14

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

101

0.84

0.13

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

125

1.13

0.12

1.1

1.3

233.00

153.48

miu/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

190

1.09

0.10

1.6

—

(4034850) Laboratory test

312

0.93

0.10

10.4

9.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

176

0.91

0.10

1.6

1.3

—

(3024263) Appearance of Synovial fluid

1.11

0.09

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.05

0.08

2.5

3.1

210.67

217.52

u/l

—

(3048689) Calprotectin [Mass/mass] in Stool

892

0.97

0.08

2.0

2.1

106.07

161.81

ug/g

1.51

700

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.81

0.08

1.0

—

(3011412) CD3 cells [#/volume] in Blood

0.80

0.08

6.8

2.0

1.29

0.96

e9/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

347

0.95

0.08

1.1

1.0

—

(3037121) Protein [Mass/volume] in Urine

387

1.05

0.08

2.0

3.0

0.18

0.34

g/l

—

161

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.82

0.07

2.5

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.08

0.07

1.0

1.1

—

25.50

—

(3051611) Lipemic interference index of Serum or Plasma

129

1.10

0.07

4.4

3.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.05

0.07

1.1

1.2

10.37

20.49

u/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.03

0.07

1.1

1.2

58.75

90.37

u/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.03

0.07

1.8

1.6

3.75

4.74

u/l

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.05

0.07

1.4

1.2

—

nmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.88

0.06

3.1

2.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.12

0.06

1.1

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.89

0.06

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

110

1058

0.98

0.06

1.2

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

121

1.09

0.06

1.6

1.4

—

(3019060) Gas panel - Arterial blood

735

1.03

0.06

6.2

3.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

372

0.96

0.05

3.2

3.1

0.82

0.81

nmol/l

0.08

274

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

524

0.97

0.05

2.4

3.8

24.47

24.15

mmol/l

0.26

508

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.11

0.05

1.1

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

303

2832

1.01

0.04

3.9

3.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

216

1.05

0.04

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1035

9775

0.99

0.04

4.3

4.1

1.94

2.26

mu/l

1.36

892

8538

(3023103) Potassium [Moles/volume] in Serum or Plasma

1267

11959

0.99

0.04

19.1

16.8

3.99

4.00

mmol/l

0.48

1174

11512

(3003396) Base excess in Arterial blood by calculation

138

1315

0.99

0.03

5.9

5.8

1.24

1.02

mmol/l

0.29

106

993

(3012501) Base excess in Blood by calculation

255

1.03

0.02

2.8

4.5

2.74

2.87

mmol/l

0.11

181

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

138

1312

0.99

0.02

5.8

4.98

5.07

kpa

0.43

124

1226

(3004616) Nuclear Ab [Presence] in Serum

106

1.07

0.02

1.1

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

138

1311

0.99

0.02

5.8

11.78

11.87

kpa

0.05

124

1224

(3013290) Carbon dioxide [Partial pressure] in Blood

256

1.03

0.02

2.8

4.5

5.22

5.00

kpa

0.45

250

(3008757) Leukocyte morphology finding [Identifier] in Blood

129

0.95

0.01

1.8

5.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

116

1.06

0.01

1.1

56.92

57.00

u/l

0.00

103

(3019550) Sodium [Moles/volume] in Serum or Plasma

1267

11921

1.00

0.01

19.2

16.6

140.01

139.57

mmol/l

5.36

1179

11495

(3004775) Volume in Urine collected for unspecified duration

107

1.06

0.01

2.1

1.9

732.14

662.24

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

286

1.02

0.00

2.0

2.1

19.03

94.57

ug/min

2.54

154

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

213

0.97

0.00

1.2

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

109

0.95

0.00

1.5

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

109

0.95

0.00

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

212

0.98

0.00

1.2

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

198

1.00

0.00

1.9

2.4

—

(3038515) Glucose [Moles/volume] in Venous blood

322

0.99

0.00

3.0

3.1

8.83

7.95

mmol/l

0.62

313

(3003181) Sodium [Moles/volume] in Urine

172

0.99

0.00

1.3

80.92

62.65

mmol/l

0.82

135

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

194

1.02

0.00

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

374.80

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

2.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.90

-0.00

3.3

7.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.98

-0.00

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.2

—

0.15

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

15.64

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

102.50

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.91

-0.00

3.2

2.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.93

-0.00

1.2

1.03

1.63

nmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.00

-0.00

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.1

—

11.13

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.95

-0.00

1.8

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

1.55

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

389.80

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.98

-0.00

6.6

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

12.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.9

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

2.8

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AD_EO_EXMORE – Alzheimer’s disease (Early onset), excluding more controls

GWS hits: 5

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer’s disease (Early onset), excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints